GBT
IDXX icon

Grove Bank & Trust’s Idexx Laboratories IDXX Stock Holding History

Grove Bank & Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Sell
710
-396
-36% -$222K 0.04% 197
2026
Q1 		$621K Sell
1,106
-654
-37% -$419K 0.07% 146
2025
Q4 		$1.19M Sell
1,760
-974
-36% -$663K 0.13% 102
2025
Q3 		$1.75M Sell
2,734
-173
-6% -$105K 0.2% 81
2025
Q2 		$1.56M Buy
2,907
+2,870
+7,757% +$1.37M 0.19% 85
2025
Q1 		$15.5K Hold
37
– – ﹤0.01% 553
2024
Q4 		$15.3K Buy
37
+5
+16% +$2.19K ﹤0.01% 495
2024
Q3 		$16.2K Buy
32
+12
+60% +$5.83K ﹤0.01% 458
2024
Q2 		$9.74K Sell
20
-5
-20% -$2.51K ﹤0.01% 483
2024
Q1 		$13.5K Hold
25
– – ﹤0.01% 473
2023
Q4 		$13.9K Hold
25
– – ﹤0.01% 462
2023
Q3 		$10.9K Hold
25
– – ﹤0.01% 511
2023
Q2 		$12.6K Sell
25
-7
-22% -$3.35K ﹤0.01% 486
2023
Q1 		$16K Buy
32
+27
+540% +$12.9K ﹤0.01% 477
2022
Q4 		$2K Buy
+5
New +$1.94K ﹤0.01% 571

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Grove Bank & Trust's IDXX Position: Q2 2026 in Review

Grove Bank & Trust reduced its Idexx Laboratories (IDXX) stake by 36% in Q2 2026, selling an estimated $222K and leaving 710 shares worth $374K. The position accounts for 0.04% of the portfolio, ranked #197.

Grove Bank & Trust first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.75M in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Grove Bank & Trust held 710 shares of Idexx Laboratories worth $374K as of Q2 2026.
  • Grove Bank & Trust sold 396 Idexx Laboratories shares in Q2 2026, an estimated $222K.
  • Idexx Laboratories made up 0.04% of Grove Bank & Trust's portfolio in Q2 2026, its #197 holding.
  • Grove Bank & Trust first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Grove Bank & Trust's Idexx Laboratories position peaked at $1.75M in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.